Quick Answer
Astrana Health, Inc. reported Cash and Equivalents of $429.47 million for fiscal year 2025.
Astrana Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $429.47M | +48.9% |
| 2024 | $288.45M | -1.8% |
| 2023 | $293.81M | +2.0% |
| 2022 | $288.03M | +23.6% |
| 2021 | $233.10M | +20.5% |
| 2020 | $193.47M | +87.5% |
| 2019 | $103.19M | -3.5% |
| 2018 | $106.89M | +7.2% |
| 2017 | $99.75M | +1051.3% |
| 2017 | $8.66M | -84.2% |
| 2016 | $54.82M | +491.4% |
| 2016 | $9.27M | -84.3% |
| 2015 | $59.01M | +1076.9% |
| 2015 | $5.01M | -26.6% |
| 2014 | $6.83M | +370.7% |
| 2014 | $1.45M | +23.3% |
| 2013 | $1.18M | +615.9% |
| 2012 | $164.4K | -58.6% |
| 2011 | $397.1K | -40.4% |
| 2010 | $665.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $462.23M | +32.8% | +36.1% |
| June 30, 2025 | $339.70M | +4.4% | +31.4% |
| March 31, 2025 | $258.52M | -22.8% | -10.4% |
| December 31, 2024 | $288.45M | -1.8% | -17.1% |
| September 30, 2024 | $347.99M | +27.0% | +7.0% |
| June 30, 2024 | $325.31M | +10.7% | -2.8% |
| March 31, 2024 | $334.80M | +21.9% | +14.0% |
| December 31, 2023 | $293.81M | +2.0% | +7.3% |
- Astrana Health, Inc. showed an increase of +48.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, Astrana Health, Inc.’s cash and equivalents has grown by 64411.1% (from $665.7 thousand to $429.47 million).
- The most recent figure is from Astrana Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: